中國醫療集團(08225.HK)擬在海南建立大型臨牀研究中心
格隆匯 3 月 29日丨中國醫療集團(08225.HK)發佈公吿,集團旗下子公司與海南政府簽署五年戰略合作協定,就於全球最大自貿島建立臨牀研究中心和政府獎勵達成協議。集團通過在海南建立大型臨牀研究中心,將更加突出集團在腦科學、抗過敏和抗病毒三大領域的臨牀研究優勢地位,更好地覆蓋五大專科的臨牀研究:喜心精神心理、拜敏抗過敏、悦戒癮、健壽抗痴卒、罕見萬全,管理層相信集團的業績將會受政策積極影響而快速提升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.